{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Avaria%20Health%20%26%20Beauty%20Corp.","name":"Avaria Health & Beauty Corp.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-05T10:29:17.400Z"},"count":2,"matches":[{"id":"b6bfef9e1f627c5e","posted_date":"2024-09-10","letter_issue_date":"2024-09-03","company_name":"Avaria Health & Beauty Corp.","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/b6bfef9e1f627c5e"},{"id":"83e4984a1a21dc5e","posted_date":"2023-08-08","letter_issue_date":"2023-08-03","company_name":"Avaria Health & Beauty Corp.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/83e4984a1a21dc5e"}]}